Nailfold capillaroscopy: Specific features in Fabry disease

Clinical Hemorheology and Microcirculation

Volumn 42, Issue 2, 2009, Pages 99-106

  Wasik, Jan S ^a   Simon, Roger W ^a   Meier, Thomas ^a   Steinmann, Beat ^b   Amann Vesti, Beatrice R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Fabry disease; Microangiopathy; Nailfold capillaroscopy

Indexed keywords

FLUORESCEIN; SODIUM;

ADULT; AGED; ARTICLE; CAPILLAROSCOPY; CAPILLARY DENSITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; HUMAN; IN VIVO STUDY; KIDNEY FAILURE; MALE; RAYNAUD PHENOMENON; ANGIOSCOPY; METHODOLOGY; MIDDLE AGED; NAIL; PATHOLOGY; VASCULARIZATION;

ADULT; AGED; FABRY DISEASE; FEMALE; HUMANS; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; RAYNAUD DISEASE; RENAL INSUFFICIENCY;

EID: 67649804869     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1158     Document Type: Article

References (25)

1. B.R. Amann-Vesti, G. Gitzelmann, U. Widmer, N.U. Bosshard, B. Steinmann and R. Koppensteiner, Severe lymphatic microangiopathy in Fabry disease, Lymphat. Res. Biol. 1 (2003), 185-189.]
2. G.A. Ashley, J. Shabbeer, M. Yasuda, C.M. Eng and R.J. Desnick, Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype, J. Hum. Genet. 46 (2001), 192-196.
3. A. Bollinger and B. Fagrell, Clinical Capillaroscopy. A Guide to Its Use in Clinical Research and Practice, Hogrefe & Huber, Toronto, Lewiston, NY, 1990.
4. A. Bollinger, K. Jager and W. Siegenthaler, Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy, Arch. Intern. Med. 146 (1986), 1541-1545.
5. K.E. Crutchfield, N.J. Patronas, J.M. Dambrosia, K.P. Frei, T.K. Banerjee, N.W. Barton et al., Quantitative analysis of cerebral vasculopathy in patients with Fabry disease, Neurology 50 (1998), 1746-1749.
6. R.J. Desnick, M. Banikazemi and M. Wasserstein, Enzyme replacement therapy for Fabry disease, an inherited nephropa-thy, Clin. Nephrol. 57 (2002), 1-8.
7. R.J. Desnick, H.S. Bernstein, K.H. Astrin and D.F. Bishop, Fabry disease: molecular diagnosis of hemizygotes and het-erozygotes, Enzyme 38 (1987), 54-64.
8. R.J. Desnick, L.C. Blieden, H.L. Sharp, P.J. Hofschire and J.H. Moller, Cardiac valvular anomalies in Fabry disease: Clinical, morphologic, and biochemical studies, Circulation 54 (1976), 818-825.
9. R.J. Desnick, R. Brady, J. Barranger, A.J. Collins, D.P. Germain, M. Goldman et al., Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy, Ann. Intern. Med. 138 (2003), 338-346.
10. R.J. Desnick, Y.A. loannou and C.M. Eng, Alpha-galactosidase A deficiency: Fabry disease, in: The Metabolic andMolec- ular Bases of Inherited Disease, C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs, K.W. Kinzler and B. Vogelstein, eds, McGraw-Hill, New York, 1995, pp. 3733-3774.
11. N.A. Flavahan and P.M. Vanhoutte, Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins, J. Pharmacol. Exp. Ther. 238 (1986), 131-138.
12. J. Frank, W. Jansen-Genzel, A. Lentner and V. Wienert, Angiokeratoma corporis diffusum universale (Fabry disease), Hautarzt 47 (1996), 776-779.
13. M.E. Goldman, R. Cantor, M.F. Schwartz, M. Baker and R.J. Desnick, Echocardiographic abnormalities and disease severity in Fabry's disease, J. Am. Coll. Cardiol. 7 (1986), 1157-1161.
14. W. Grassi, P.D. Medico, F. Izzo and C. Cervini, Microvascular involvement in systemic sclerosis: capillaroscopic findings, Semin. Arthrit. Rheum. 30 (2001), 397-402.
15. P. Kahn, Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain, J. Neurol. Neurosurg. Psychiatr. 36 (1973), 1053-1062.
16. J.G. Kenik, H.R. Maricq and G.G. Bole, Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases, Arthritis Rheum. 24 (1981), 885-891.
17. P. Lemansky, D.F. Bishop, R.J. Desnick, A. Hasilik and K. von Figura, Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease, J. Biol. Chem. 262 (1987), 2062-2065.
18. H.R. Maricq, G. Spencer-Green and E.C. Leroy, Abnormal capillary patterns and systemic disease in scleroderma (progressive systemic sclerosis), Bibl. Anat. 13 (1975), 248-249.
19. A.T. Masi, Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity, J. Rheumatol. 15 (1988), 894-898.
20. A. Mehta, R. Ricci, U. Widmer, F. Dehout, A. Garcia de Lorenzo, C. Kampmann et al., Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey, Eur. J. Clin. Invest. 34 (2004), 236-242.
21. P.J. Meikle, J.J. Hopwood, A.E. Clague and W.F. Carey, Prevalence of lysosomal storage disorders, JAMA 281 (1999), 249-254.
22. M. Meli, G. Gitzelmann, R. Koppensteiner and B.R. Amann-Vesti, Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon, Clin. Rheumatol. 25 (2006), 153-158.
23. H. Sakuraba, Y. Yanagawa, T. Igarashi, T. Suzuki, K. Watanabe, K. leki et al., Cardiovascular manifestations in Fabry's disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes, Clin. Genet. 29 (1986), 276-283.
24. J.A. Schmidt, L. Caspary, A. von Bierbrauer, A.M. Ehrly, M. Junger and F. Jung, Standardization of nailfold capillary microscopy in routine diagnosis, Vasa 26 (1997), 5-10.
25. N.A. Sher, R.D. Letson and R.J. Desnick, The ocular manifestations in Fabry's disease, Arch. Ophthalmol. 97 (1979), 671-676